Nexcelom Bioscience LLC

Ambit Biosciences Corporation is a biopharmaceutical company based in San Diego, CA, dedicated to the discovery, development, and commercialization of innovative drugs targeting unmet medical needs in oncology, autoimmune, and inflammatory diseases. The company focuses on inhibiting kinases that drive these diseases, with a robust pipeline that includes internally discovered programs aimed at validated kinase targets. The company's lead drug candidate, quizartinib, is a potent and selective FLT3 kinase inhibitor administered once daily, currently in development for treating acute myeloid leukemia (AML). Ambit leverages its kinase expertise to optimize and develop a sustainable pipeline of small molecule kinase inhibitors, positioning itself as a key partner in the field. Generated from the website

Verogen, Inc., a San Diego-based company, has recently been acquired by QIAGEN, a global leader in Sample to Insight solutions for molecular testing. Verogen specializes in providing innovative products and services for human identification, offering a range of DNA sequencing kits, analysis software, and support resources for forensic and investigative genetic genealogy applications. With a focus on STRs, mitochondrial DNA, and externally visible characteristics, Verogen's products enable accurate and efficient DNA analysis. Their comprehensive offerings, including the ForenSeq DNA Signature Prep Kit and MiSeq FGx Sequencing System, empower law enforcement agencies and researchers to unlock the potential of next-generation sequencing technology in human identification. As part of QIAGEN, Verogen continues to advance the field of forensic genetics while upholding corporate social responsibility and sustainability.Generated from the website

Nielsen Biosciences, Inc. is a privately held biopharmaceutical company based in San Diego, California, dedicated to developing and commercializing biological products that leverage cell-mediated immune responses. The company is actively engaged in clinical trials, including a Phase 3 study evaluating CANDIN for the treatment of human papillomavirus (HPV) conditions such as common warts. In addition to CANDIN, Nielsen Biosciences offers Spherusol, a skin test antigen for detecting delayed-type hypersensitivity to Coccidioides immitis, the causative agent of Valley Fever. Both products are designed to assess and monitor immune responses, contributing to advancements in immunotherapy and patient care. Generated from the website